Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
The Navitas Advantage: Powering the Future of Pharma & Biotech In today’s fast-moving world of pharma and biotech, innovation isn’t just an advantage—it’s a necessity. Scientific breakthroughs, evolving global regulations, and the relentless demand for speed and quality are rewriting the rules of drug development. To...
In a world where scientific innovation is accelerating fast, regulatory strategy is a competitive advantage. Pharma & biotech companies need clarity and deep multidisciplinary insight into the regulatory environment and the paths that competitors are taking to bring safe, effective products to market quickly. Whether developing a first-in-class...
Are you ready to lead the next wave of transformation in life sciences? Across Navitas’ industry-leading networks, pvnet®, pvconnect®, labelnet™, and more, over 100+ member companies are rewriting the playbook for 2026. Here’s what’s setting the pace for the industry’s boldest innovators: 1. Technology &...
New “Ask Your Biostatistician” Video Clinical trials generate data from dozens of sources, EDC systems, laboratories, imaging vendors, safety platforms, wearables and ePRO devices. Ensuring all of it aligns is essential for clinical trial data quality, trustworthy analyses and regulatory submission readiness. This ongoing discipline, ...
Pharma’s digital maturity has accelerated recently, and emerging technologies are core enablers of faster R&D. As we move into 2026, five digital technologies stand out as the most transformative in the biopharma industry. 1. Big Data Platforms & Intelligence-Driven RWE Ecosystems Modern R&D relies on the seamless flow of clinica...
The complexities and challenges of data is increasing at an unprecedented rate and excellence in Clinical Data Management (CDM) has become a defining factor of success. Pharmaceutical and biotech companies are looking for partners who not only manage data but transform it into meaningful insights that drive smarter and more compliant decisions. In ...
The second Navitas Life Sciences Ad Promo Roundtable, held on September 25, 2025, convened more than forty experts from across global pharma to examine recent U.S. FDA actions on Direct-to-Consumer (DTC) advertising. Highlights from the Second Ad Promo Roundtable The session was Co-Hosted by Bob Dean, Head of Global Labeling Strategy and Ad/Promo, ...
Be First-to-Market with Our Bioavailability & Bioequivalence (BABE) CRO Services Bioavailability (BA) and Bioequivalence (BE) studies are critical components in developing or marketing a generic drug. To secure approval from global health authorities such as the US FDA, pharmaceutical companies must conduct a bioequivalence study comparing thei...
Navitas Life Sciences’ medical information contact center (MICC) services help global clients achieve operational excellence, ensure compliance and enhance customer satisfaction while significantly reducing costs. Our proven approach recently enabled a leading global pharmaceutical company to achieve a 30% cost reduction through an integrate...
Insights from the PHUSE Chennai SDE Navitas Life Sciences was proud to be part of the highly attended PHUSE India SDE in Chennai, sharing our expertise in biostatistics, data sciences, and regulatory submissions. We were recognized as a Major Contender in the Everest Group Clinical Data Management Operations PEAK Matrix® Assessment 2025, which...